Kari B. Wisinski
University of Wisconsin–Madison(US)University of Wisconsin Carbone Cancer Center(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, PI3K/AKT/mTOR signaling in cancer, Breast Cancer Treatment Studies
Most-Cited Works
- → Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology(2021)1,099 cited
- → Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology(2022)945 cited
- → NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020(2020)498 cited
- → Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology(2024)459 cited
- → NCCN Guidelines® Insights: Breast Cancer, Version 4.2023(2023)415 cited
- → NCCN Guidelines® Insights: Breast Cancer, Version 4.2021(2021)348 cited
- → CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis